Close Menu

NEW YORK – Personal Genome Diagnostics (PGDx) said on Wednesday that it has entered a strategic collaboration with the Mayo Clinic to improve clinical diagnostic oncology solutions. 

As part of the collaboration, the partners will focus on optimizing technology and conducting clinical utility studies for liquid biopsy and tissue-based genomic applications, combining Mayo Clinic's clinical knowledge and expertise in oncology and PGDx's experience with genomic technology. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.